Literature DB >> 10341092

Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene.

S C Guru1, J S Crabtree, K D Brown, K J Dunn, P Manickam, N B Prasad, D Wangsa, A L Burns, A M Spiegel, S J Marx, W J Pavan, F S Collins, S C Chandrasekharappa.   

Abstract

The mouse homolog of the human MEN1 gene, which is defective in a dominant familial cancer syndrome, multiple endocrine neoplasia type 1 (MEN1), has been identified and characterized. The mouse Men1 transcript contains an open reading frame encoding a protein of 611 amino acids which has 97% identity and 98% similarity to human menin. Sequence of the entire Men1 gene (9.3 kb) was assembled, revealing 10 exons, with exon 1 being non-coding; a polymorphic tetranucleotide repeat was located in the 5'- flanking region. The exon-intron organization and the size of the coding exons 2-9 were well conserved between the human and mouse genes. Fluorescence in situ hybridization localized the Men1 gene to mouse Chromosome (Chr) 19, a region known to be syntenic to human Chr 11q13, the locus for the MEN1 gene. Northern analysis indicated two messages-2.7 kb and 3.1 kb-expressed in all stages of the embryo analyzed and in all eight adult tissues tested. The larger transcript differs from the smaller by the inclusion of an unspliced intron 1. Whole-mount in situ hybridization of 10.5-day and 11.5-day embryos showed ubiquitous expression of Men1 RNA. Western analysis with antibodies raised against a conserved C-terminal peptide identified an approximately 67-kDa protein in the lysates of adult mouse brain, kidney, liver, pancreas, and spleen tissues, consistent with the size of human menin. The levels of mouse menin do not appear to fluctuate during the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10341092     DOI: 10.1007/s003359901051

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  19 in total

Review 1.  Multiple endocrine neoplasia type 1.

Authors:  M L Brandi
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Menin induces endodermal differentiation in aggregated P19 stem cells by modulating the retinoic acid receptors.

Authors:  Jyotshnabala Kanungo; Settara C Chandrasekharappa
Journal:  Mol Cell Biochem       Date:  2011-08-11       Impact factor: 3.396

3.  Neuron-Specific Menin Deletion Leads to Synaptic Dysfunction and Cognitive Impairment by Modulating p35 Expression.

Authors:  Kai Zhuang; Changquan Huang; Lige Leng; Honghua Zheng; Yuehong Gao; Guimiao Chen; Zhilin Ji; Hao Sun; Yu Hu; Di Wu; Meng Shi; Huifang Li; Yingjun Zhao; Yunwu Zhang; Maoqiang Xue; Guojun Bu; Timothy Y Huang; Huaxi Xu; Jie Zhang
Journal:  Cell Rep       Date:  2018-07-17       Impact factor: 9.423

4.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Expression and subcellular localization of menin in human cancer cells.

Authors:  Feng Ren; Hong-Wei Xu; Yu Hu; Shuang-Hong Yan; Feng Wang; Bao-Wei Su; Qi Zhao
Journal:  Exp Ther Med       Date:  2012-03-29       Impact factor: 2.447

Review 6.  Menin: a scaffold protein that controls gene expression and cell signaling.

Authors:  Smita Matkar; Austin Thiel; Xianxin Hua
Journal:  Trends Biochem Sci       Date:  2013-07-10       Impact factor: 13.807

7.  Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.

Authors:  H-C Jennifer Shen; Mei He; Anathea Powell; Asha Adem; Dominique Lorang; Charles Heller; Amelia C Grover; Kris Ylaya; Stephen M Hewitt; Stephen J Marx; Allen M Spiegel; Steven K Libutti
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

8.  Of mice and MEN1: Insulinomas in a conditional mouse knockout.

Authors:  Judy S Crabtree; Peter C Scacheri; Jerrold M Ward; Sara R McNally; Gary P Swain; Cristina Montagna; Jeffrey H Hager; Douglas Hanahan; Helena Edlund; Mark A Magnuson; Lisa Garrett-Beal; A Lee Burns; Thomas Ried; Settara C Chandrasekharappa; Stephen J Marx; Allen M Spiegel; Francis S Collins
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  The menin tumor suppressor protein is phosphorylated in response to DNA damage.

Authors:  Joshua Francis; Wenchu Lin; Orit Rozenblatt-Rosen; Matthew Meyerson
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

10.  Molecular alterations in sporadic primary hyperparathyroidism.

Authors:  Maria Inês Alvelos; Maria Mendes; Paula Soares
Journal:  Genet Res Int       Date:  2011-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.